ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Breast Cancer

Lung Cancer trials near Austin, TX, USA:

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...

Enrolling
Small Cell Lung Cancer (SCLC)
Drug: Chemotherapy
Drug: PF-08634404

Phase 2, Phase 3

Pfizer
Pfizer

New Braunfels, Texas, United States and 31 other locations

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Enrolling
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

Austin, Texas, United States and 32 other locations

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: sigvotatug vedotin
Drug: docetaxel

Phase 3

Seagen, a wholly owned subsidiary of Pfizer

Austin, Texas, United States and 337 other locations

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Durvalumab
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 230 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Round Rock, Texas, United States and 300 other locations

(pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung cancer (NSCLC)...

Enrolling
Carcinoma, Non-Small-Cell Lung (NSCLC)
Lung Cancer
Biological: Pembrolizumab
Biological: PF-08634404

Phase 3

Pfizer
Pfizer

Austin, Texas, United States and 249 other locations

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs gro...

Enrolling
Non-Squamous Non-Small Cell Lung Cancer
Drug: Standard of Care
Drug: Telisotuzumab Adizutecan

Phase 2, Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 52 other locations

this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung...

Enrolling
Small-cell Lung Cancer
Drug: ZL-1310
Drug: Investigator's Choice of Therapy

Phase 3

Zai Lab
Zai Lab

Austin, Texas, United States and 55 other locations

This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung...

Enrolling
Non Small Cell Lung Cancer
Drug: WSD0922-FU Tablets, Dose level A
Drug: WSD0922-FU Tablets, Dose level B

Phase 2

Wayshine Biopharm, Inc.

Austin, Texas, United States and 17 other locations

survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) among adults with metastatic non-small cell lung...

Active, not recruiting
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Drug: carboplatin plus paclitaxel
Other: Placebo

Phase 3

Immutep

Austin, Texas, United States and 146 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems